Acme United Corporation (ACU) Earnings Call Transcripts

28 earnings calls from February 2020 to July 23, 2026

NYSEAM US Health Care Health Care Equipment and Supplies

Acme United Corporation's Latest Earnings Call - Q1 FY2026

In the first quarter of 2026, Acme United Corporation (ACU:US) reported net sales of $52.3 million, a 14% increase year-over-year, but net income fell to $985,000 from $1.6 million, resulting in earnings per share of $0.24, down from $0.41. The decline in profitability was attributed to higher tariffs and increased costs associated with recent acquisitions, particularly the Mimetic business. Management indicated that while current challenges exist, they expect improvements in gross margins and overall performance as tariff impacts lessen in the coming quarters.

Reported metrics

MetricValueContext
Net Sales $52.3 million (beat) vs $46 million in Q1 2025, +14% YoY
Net Income $985,000 (miss) vs $1.6 million in Q1 2025, -40% YoY
EPS $0.24 (miss) vs $0.41 in Q1 2025, -41% YoY
Gross Margin 39.7% (inline) vs 39% in Q1 2025
SG&A Expenses $19 million (negative) 36% of net sales vs $15.5 million or 34% in Q1 2025
Free Cash Flow $14.2 million (null) before $6 million facility purchase

Guidance from management

Management expects a gradual improvement in profitability as tariff impacts decline over the next three quarters, with a return to normal levels anticipated by Q3 2026.

What management said

Good morning. Welcome to the First Quarter 2026 Earnings Conference Call for Acme United Corporation. I am Walter C. Johnsen, Chairman and CEO. With me is Paul Driscoll, our Chief Financial Officer, who will first read the safe harbor statement. Paul?
— Walter Johnsen, Q1 FY2026 earnings call
Well, it's -- Yes. Well, it's not getting approval. We could sell them now, but you wanted to have it done right. In fact, our products do get sold into hospitals now. But when we get done with the project, and we're about 3 quarters done we'll have a facility that we'll be very proud to take major distributors in the United States to visit and do their own audits, and we'll have confidence that we've really done the...
— Walter Johnsen, Q1 FY2026 earnings call

What analysts pressed on

Analysts expressed concerns over the impact of tariffs on margins and the effectiveness of recent acquisitions in driving growth. There were questions about the sustainability of SG&A expenses and the potential for further inventory write-downs due to geopolitical tensions.

Main topics on the call

Read the full Acme United Corporation transcript (Q1 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

About Acme United Corporation

Acme United Corporation (ACU) is a publicly listed company in the Health Care Equipment and Supplies industry, within the Health Care sector. It trades on NYSEAM and is based in US. EarningsCalls.dev maintains a free, full-text archive of its earnings call transcripts — 28 calls on record spanning February 27, 2020 to July 23, 2026. Every transcript is split into speaker-by-speaker segments with headline metrics, free to read or available through our REST API.

Earnings Call History

EarningsCalls.dev has 28 Acme United Corporation earnings call transcripts on record, spanning February 27, 2020 to July 23, 2026. Based on this history, Acme United Corporation reports quarterly. The most recent call on file is dated July 23, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker
ACU
Exchange
NYSEAM
Country
US
Sector
Health Care
Industry
Health Care Equipment and Supplies
Calls on record
28
First call
February 27, 2020
Most recent
July 23, 2026
Reporting cadence
quarterly
Quarter Date
Q2 FY2026 Jul 23, 2026 Read transcript
Q1 FY2026 Apr 23, 2026 Read transcript
Q4 FY2025 Feb 26, 2026 Read transcript
Q2 FY2025 Jul 23, 2025 Read transcript
Q1 FY2025 Apr 17, 2025 Read transcript
Q4 FY2024 Feb 28, 2025 Read transcript
Q3 FY2024 Oct 18, 2024 Read transcript
Q2 FY2024 Jul 19, 2024 Read transcript
Q1 FY2024 Apr 19, 2024 Read transcript
Q4 FY2023 Mar 1, 2024 Read transcript
Q3 FY2023 Oct 23, 2023 Read transcript
Q2 FY2023 Jul 21, 2023 Read transcript
Q1 FY2023 Apr 21, 2023 Read transcript
Q4 FY2022 Mar 2, 2023 Read transcript
Q3 FY2022 Oct 21, 2022 Read transcript
Q2 FY2022 Jul 22, 2022 Read transcript
Q1 FY2022 Apr 22, 2022 Read transcript
Q4 FY2021 Mar 1, 2022 Read transcript
Q3 FY2021 Oct 26, 2021 Read transcript
Q2 FY2021 Jul 22, 2021 Read transcript
Shareholder/Analyst Calls Apr 20, 2021 Read transcript
Q1 FY2021 Apr 19, 2021 Read transcript
Q4 FY2020 Mar 3, 2021 Read transcript
Q3 FY2020 Oct 21, 2020 Read transcript
Q2 FY2020 Jul 17, 2020 Read transcript
Shareholder/Analyst Calls Apr 20, 2020 Read transcript
Q1 FY2020 Apr 17, 2020 Read transcript
Q4 FY2019 Feb 27, 2020 Read transcript